News & Updates

Show Multimedia Only

Ibrexafungerp: A potential solution for intolerance to standard antifungals?

11 Nov 2022 by

Patients who are refractory or intolerant to currently approved antifungal therapies exhibited a positive response to the novel triterpenoid antifungal ibrexafungerp, according to interim analysis results of the phase III FURI trial.

11 Nov 2022

Caffeine consumption during pregnancy tied to shorter stature in children

10 Nov 2022

Children born to mothers with increased intake of caffeine and paraxanthine during pregnancy are likely to have shorter stature, which persists up to 8 years of age, according to a study.

10 Nov 2022

Extreme temperatures up risk of stillbirth

09 Nov 2022

Pregnant women exposed to extreme heat or cold see a significantly excess risk of stillbirth, especially during the third trimester, reports a recent study.

09 Nov 2022

Menopause occurs early among women with diabetes

09 Nov 2022

Women appear to experience premature menopause in the presence of diabetes, according to a study.

09 Nov 2022

Ovarian reserve damage less with ablation vs cystectomy for endometrioma

07 Nov 2022

In the treatment of patients with endometrioma, both ablation and cystectomy cause significant damage to ovarian reserve, although the extent of damage appears to be less with ablation, as shown in a study.

07 Nov 2022

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

07 Nov 2022 by

For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.

07 Nov 2022

Dextromethorphan offers no benefit for relieving pain during medication abortion

05 Nov 2022

Dextromethorphan, when used in addition to standard analgesics, falls short of reducing the pain experienced by women undergoing medication abortion, according to a trial.

05 Nov 2022

Kisspeptin shows promise in women with hypoactive sexual desire disorder

03 Nov 2022

The use of kisspeptin appears to restore sexual and facial attraction brain processing in premenopausal women with hypoactive sexual desire disorder, without an accompanying increase in the risk of adverse effects, a study has found.

03 Nov 2022